Literature review · Muscle & strength

GHRP-6

An acute human challenge study supports an interaction between GHRP-6 and endogenous GHRH in GH secretion. It does not establish a strength or recovery benefit.

By HeartPep · Reviewed · 3 selected source records

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

At a glance

Selected acute human studies examine GH-axis mechanism, EEG sleep stages and route-dependent endocrine responses. None of these endpoints establishes a muscle or strength benefit.

Identity & scope

The cited material is the named GH-releasing peptide GHRP-6. Similar GH-axis activity does not make other GHRPs interchangeable.

Catalogue labels covered: GHRP-6.

What the research shows

  • A receptor-axis experiment can show how a hormone response depends on another signal. It cannot show that changing the signal improves a person’s performance.

Critical interpretation

Separate a mechanistic test from a sleep outcome

The antagonist experiment supports a role for endogenous GHRH in the acute GH response. The sleep-laboratory experiment asks a different question and records stage 2 sleep alongside GH, ACTH and cortisol. Slow-wave sleep did not increase in that experiment. A change in one EEG stage cannot establish improved insomnia, restorative sleep or next-day functioning, and the accompanying adrenal-hormone changes mean the response should not be described as selectively releasing GH. [1] [2]

Route-specific findings include null results and trends

The later study compared specified oral, nasal and sublingual preparations under placebo conditions. Results varied by route; several reported differences were trends rather than statistically established effects. This is useful evidence against collapsing all delivery formats into a single outcome claim. It also prevents a significant GH result in the nasal arm from being presented as a demonstrated sleep benefit. The study concerns its own preparations and experimental schedule, not every spray carrying the GHRP-6 name. [3]

Limitations & uncertainties

  • Only nine healthy men were studied in this experiment.
  • The results do not establish effects of long-term exposure, a nasal formulation or a supplier product.

Open research questions

  • Which functional endpoint, beyond a circulating hormone marker, would test the proposed hypothesis?
  • What is the exact material specification and how does it relate to the cited preparation?

Selected papers & source records

Download bibliography
Human studyNamed compoundAbstract / record checked

1. Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation (opens in a new tab)

Pandya N, DeMott-Friberg R, Bowers CY, Barkan AL, Jaffe CA. (1998). Journal of Clinical Endocrinology & Metabolism. DOI: 10.1210/jcem.83.4.4711 (opens in a new tab) · PMID 9543138

Design & population
Physiological challenge experiment in nine healthy men, comparing GHRP-6 responses with and without a GHRH antagonist.
What the study found
Blocking GHRH removed most of the GH response to GHRP-6, supporting a role for endogenous GHRH in that response.
Limits on interpretation
An acute endocrine mechanism experiment, not a trial of strength, recovery, weight control or nasal products.
Human studyNamed compoundAbstract / record checked

2. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man (opens in a new tab)

Frieboes RM, Murck H, Maier P, et al. (1995). Neuroendocrinology. DOI: 10.1159/000126883 (opens in a new tab) · PMID 7617137

Design & population
Placebo-comparison sleep-laboratory experiment in healthy men, combining overnight EEG with GH, ACTH and cortisol measurements.
What the study found
Stage 2 sleep increased, but slow-wave sleep and other sleep-EEG variables did not. ACTH and cortisol rose alongside GH.
Limits on interpretation
Acute experimental sleep architecture and hormone measurements, without an insomnia-treatment or next-day-function outcome. The response was not GH-selective.
Human studyNamed compoundAbstract / record checked

3. Effects of growth hormone-releasing peptide-6 on the nocturnal secretion of GH, ACTH and cortisol and on the sleep EEG in man: role of routes of administration (opens in a new tab)

Frieboes RM, Murck H, Antonijevic IA, Steiger A. (1999). Journal of Neuroendocrinology. DOI: 10.1046/j.1365-2826.1999.00364.x (opens in a new tab) · PMID 10336729

Design & population
Placebo comparisons of oral, intranasal and sublingual experimental GHRP-6 preparations in healthy young men, with overnight EEG and hormone sampling.
What the study found
Results differed by route. Intranasal exposure significantly increased GH; several sleep and ACTH findings were only statistical trends. The oral preparation did not increase the measured hormones.
Limits on interpretation
Exposure and study conditions differed across routes. Statistical trends should not be reported as demonstrated sleep benefits, and study preparations do not establish catalogue-spray performance.

Search & review scope

Targeted web searches of PubMed-indexed primary research and original journal records. Selected abstracts and citation metadata were checked; full-text sections were consulted for the records explicitly labelled full-text. Retrieved records and targeted notice searches were also checked for visible corrections or retractions.. Checked 9 November 2026.

Selected primary research relevant to the named compound, its molecular specification and the endpoints described below.

Narrative selection, not a systematic review, comprehensive safety assessment or complete retraction audit. PubMed/PMC full-text access was intermittent. An abstract or selected-section review cannot replace appraisal of the complete methods, supplements and underlying data. Absence from this selection does not establish absence of research.

Recorded search terms
  • site.pubmed.ncbi.nlm.nih.gov GHRP-6 growth hormone 9543138
  • site.pubmed.ncbi.nlm.nih.gov "Growth hormone-releasing peptide-6 stimulates sleep" Frieboes
  • "10.1046/j.1365-2826.1999.00364.x" PMID

Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.

Cite this review

HeartPep. GHRP-6: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/us/research/library/ghrp-6.

HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

← All reviews and reference notes